A Trial Examining the Treatment of Common Warts With Combination Liquid Nitrogen (LN2) and Cantharidin
|ClinicalTrials.gov Identifier: NCT01084824|
Recruitment Status : Completed
First Posted : March 11, 2010
Last Update Posted : March 11, 2010
|Condition or disease||Intervention/treatment|
|Verruca Vulgaris||Drug: Liquid nitrogen and cantharidin Drug: Liquid nitrogen and topical placebo|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||70 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|
|Official Title:||A Randomized Clinical Trial Examining the Efficacy of Treatment of Cutaneous Verruca Vulgaris in Adult Patients With Combined Liquid Nitrogen Cryotherapy and Topically Applied Cantharidin|
|Study Start Date :||June 2007|
|Primary Completion Date :||June 2008|
|Study Completion Date :||September 2008|
Active Comparator: Liquid nitrogen and canthardin
Liquid nitrogen applied to wart(s), then cantharidin 1% topical applied afterwards.
Drug: Liquid nitrogen and cantharidin
Liquid nitrogen applied to wart(s), then cantharidin 1% topical applied afterward.
Placebo Comparator: Liquid nitrogen and placebo
Liquid nitrogen applied to wart(s) then placebo vehicle afterwards.
Drug: Liquid nitrogen and topical placebo
Liquid nitrogen applied to wart(s), then placebo vehicle applied thereafter.
- Percentage of common warts cleared [ Time Frame: 12 weeks ]Percentage of treated warts cleared with treatment, as measured with dermatoscopic examination, after 12 weeks.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01084824
|United States, Idaho|
|North Idaho Dermatology|
|Coeur D'Alene, Idaho, United States, 83814|
|Principal Investigator:||Richard A Flygare, PhD||TUI University; North Idaho Dermatology|